A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.

Market Analysis and Insights: Global Pharmaceutical CDMO Services Market

The global Pharmaceutical CDMO Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Pharmaceutical CDMO Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pharmaceutical CDMO Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical CDMO Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical CDMO Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical CDMO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical CDMO Services revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pharmaceutical CDMO Services Market Report

Report Metric	Details
Report Name	Pharmaceutical CDMO Services Market
CAGR	5%
Segment by Type	Drug Substance Development and Manufacturing Specialized Services Lab-based Services
Segment by Application	Innovative Medicine Patented Drug Patent Expired Drug
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited, Piramal Pharma Solutions, Siegfried Ltd, Fareva Group, FAMAR Health Care Services
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CDMO Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CDMO Services revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Pharmaceutical CDMO Services Market report?

Ans: The main players in the Pharmaceutical CDMO Services Market are Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited, Piramal Pharma Solutions, Siegfried Ltd, Fareva Group, FAMAR Health Care Services

What are the Application segmentation covered in the Pharmaceutical CDMO Services Market report?

Ans: The Applications covered in the Pharmaceutical CDMO Services Market report are Innovative Medicine, Patented Drug, Patent Expired Drug

What are the Type segmentation covered in the Pharmaceutical CDMO Services Market report?

Ans: The Types covered in the Pharmaceutical CDMO Services Market report are Drug Substance Development and Manufacturing, Specialized Services, Lab-based Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Drug Substance Development and Manufacturing

1.2.3 Specialized Services

1.2.4 Lab-based Services

1.3 Market by Application

1.3.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Innovative Medicine

1.3.3 Patented Drug

1.3.4 Patent Expired Drug

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical CDMO Services Market Perspective (2019-2030)

2.2 Global Pharmaceutical CDMO Services Growth Trends by Region

2.2.1 Pharmaceutical CDMO Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmaceutical CDMO Services Historic Market Size by Region (2019-2024)

2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Region (2025-2030)

2.3 Pharmaceutical CDMO Services Market Dynamics

2.3.1 Pharmaceutical CDMO Services Industry Trends

2.3.2 Pharmaceutical CDMO Services Market Drivers

2.3.3 Pharmaceutical CDMO Services Market Challenges

2.3.4 Pharmaceutical CDMO Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Pharmaceutical CDMO Services by Players

3.1.1 Global Pharmaceutical CDMO Services Revenue by Players (2019-2024)

3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2019-2024)

3.2 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Pharmaceutical CDMO Services, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Pharmaceutical CDMO Services Market Concentration Ratio

3.4.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2023

3.5 Global Key Players of Pharmaceutical CDMO Services Head office and Area Served

3.6 Global Key Players of Pharmaceutical CDMO Services, Product and Application

3.7 Global Key Players of Pharmaceutical CDMO Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CDMO Services Breakdown Data by Type

4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2019-2024)

4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2025-2030)

5 Pharmaceutical CDMO Services Breakdown Data by Application

5.1 Global Pharmaceutical CDMO Services Historic Market Size by Application (2019-2024)

5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmaceutical CDMO Services Market Size (2019-2030)

6.2 North America Pharmaceutical CDMO Services Market Size by Type

6.2.1 North America Pharmaceutical CDMO Services Market Size by Type (2019-2024)

6.2.2 North America Pharmaceutical CDMO Services Market Size by Type (2025-2030)

6.2.3 North America Pharmaceutical CDMO Services Market Share by Type (2019-2030)

6.3 North America Pharmaceutical CDMO Services Market Size by Application

6.3.1 North America Pharmaceutical CDMO Services Market Size by Application (2019-2024)

6.3.2 North America Pharmaceutical CDMO Services Market Size by Application (2025-2030)

6.3.3 North America Pharmaceutical CDMO Services Market Share by Application (2019-2030)

6.4 North America Pharmaceutical CDMO Services Market Size by Country

6.4.1 North America Pharmaceutical CDMO Services Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Pharmaceutical CDMO Services Market Size by Country (2019-2024)

6.4.3 North America Pharmaceutical CDMO Services Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Pharmaceutical CDMO Services Market Size (2019-2030)

7.2 Europe Pharmaceutical CDMO Services Market Size by Type

7.2.1 Europe Pharmaceutical CDMO Services Market Size by Type (2019-2024)

7.2.2 Europe Pharmaceutical CDMO Services Market Size by Type (2025-2030)

7.2.3 Europe Pharmaceutical CDMO Services Market Share by Type (2019-2030)

7.3 Europe Pharmaceutical CDMO Services Market Size by Application

7.3.1 Europe Pharmaceutical CDMO Services Market Size by Application (2019-2024)

7.3.2 Europe Pharmaceutical CDMO Services Market Size by Application (2025-2030)

7.3.3 Europe Pharmaceutical CDMO Services Market Share by Application (2019-2030)

7.4 Europe Pharmaceutical CDMO Services Market Size by Country

7.4.1 Europe Pharmaceutical CDMO Services Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Pharmaceutical CDMO Services Market Size by Country (2019-2024)

7.4.3 Europe Pharmaceutical CDMO Services Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Pharmaceutical CDMO Services Market Size (2019-2030)

8.2 China Pharmaceutical CDMO Services Market Size by Type

8.2.1 China Pharmaceutical CDMO Services Market Size by Type (2019-2024)

8.2.2 China Pharmaceutical CDMO Services Market Size by Type (2025-2030)

8.2.3 China Pharmaceutical CDMO Services Market Share by Type (2019-2030)

8.3 China Pharmaceutical CDMO Services Market Size by Application

8.3.1 China Pharmaceutical CDMO Services Market Size by Application (2019-2024)

8.3.2 China Pharmaceutical CDMO Services Market Size by Application (2025-2030)

8.3.3 China Pharmaceutical CDMO Services Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pharmaceutical CDMO Services Market Size (2019-2030)

9.2 Asia Pharmaceutical CDMO Services Market Size by Type

9.2.1 Asia Pharmaceutical CDMO Services Market Size by Type (2019-2024)

9.2.2 Asia Pharmaceutical CDMO Services Market Size by Type (2025-2030)

9.2.3 Asia Pharmaceutical CDMO Services Market Share by Type (2019-2030)

9.3 Asia Pharmaceutical CDMO Services Market Size by Application

9.3.1 Asia Pharmaceutical CDMO Services Market Size by Application (2019-2024)

9.3.2 Asia Pharmaceutical CDMO Services Market Size by Application (2025-2030)

9.3.3 Asia Pharmaceutical CDMO Services Market Share by Application (2019-2030)

9.4 Asia Pharmaceutical CDMO Services Market Size by Region

9.4.1 Asia Pharmaceutical CDMO Services Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Pharmaceutical CDMO Services Market Size by Region (2019-2024)

9.4.3 Asia Pharmaceutical CDMO Services Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Type

10.2.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Application

10.3.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Country

10.4.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Recipharm AB

11.1.1 Recipharm AB Company Details

11.1.2 Recipharm AB Business Overview

11.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction

11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.1.5 Recipharm AB Recent Developments

11.2 AMRI Global

11.2.1 AMRI Global Company Details

11.2.2 AMRI Global Business Overview

11.2.3 AMRI Global Pharmaceutical CDMO Services Introduction

11.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.2.5 AMRI Global Recent Developments

11.3 Patheon N.V.

11.3.1 Patheon N.V. Company Details

11.3.2 Patheon N.V. Business Overview

11.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction

11.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.3.5 Patheon N.V. Recent Developments

11.4 Aenova Group

11.4.1 Aenova Group Company Details

11.4.2 Aenova Group Business Overview

11.4.3 Aenova Group Pharmaceutical CDMO Services Introduction

11.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.4.5 Aenova Group Recent Developments

11.5 Catalent, Inc.

11.5.1 Catalent, Inc. Company Details

11.5.2 Catalent, Inc. Business Overview

11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction

11.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.5.5 Catalent, Inc. Recent Developments

11.6 Amatsigroup

11.6.1 Amatsigroup Company Details

11.6.2 Amatsigroup Business Overview

11.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction

11.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.6.5 Amatsigroup Recent Developments

11.7 WuXi AppTec Group

11.7.1 WuXi AppTec Group Company Details

11.7.2 WuXi AppTec Group Business Overview

11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction

11.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.7.5 WuXi AppTec Group Recent Developments

11.8 Strides Pharma Science Limited

11.8.1 Strides Pharma Science Limited Company Details

11.8.2 Strides Pharma Science Limited Business Overview

11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction

11.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.8.5 Strides Pharma Science Limited Recent Developments

11.9 Piramal Pharma Solutions

11.9.1 Piramal Pharma Solutions Company Details

11.9.2 Piramal Pharma Solutions Business Overview

11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction

11.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.9.5 Piramal Pharma Solutions Recent Developments

11.10 Siegfried Ltd

11.10.1 Siegfried Ltd Company Details

11.10.2 Siegfried Ltd Business Overview

11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction

11.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.10.5 Siegfried Ltd Recent Developments

11.11 Fareva Group

11.11.1 Fareva Group Company Details

11.11.2 Fareva Group Business Overview

11.11.3 Fareva Group Pharmaceutical CDMO Services Introduction

11.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.11.5 Fareva Group Recent Developments

11.12 FAMAR Health Care Services

11.12.1 FAMAR Health Care Services Company Details

11.12.2 FAMAR Health Care Services Business Overview

11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction

11.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.12.5 FAMAR Health Care Services Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Strides Pharma Science Limited

Piramal Pharma Solutions

Siegfried

Fareva Group

Famar Health Care Services

List of Tables

Table 1. Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Drug Substance Development and Manufacturing

Table 3. Key Players of Specialized Services

Table 4. Key Players of Lab-based Services

Table 5. Global Pharmaceutical CDMO Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Pharmaceutical CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Pharmaceutical CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Pharmaceutical CDMO Services Market Share by Region (2019-2024)

Table 9. Global Pharmaceutical CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Pharmaceutical CDMO Services Market Share by Region (2025-2030)

Table 11. Pharmaceutical CDMO Services Market Trends

Table 12. Pharmaceutical CDMO Services Market Drivers

Table 13. Pharmaceutical CDMO Services Market Challenges

Table 14. Pharmaceutical CDMO Services Market Restraints

Table 15. Global Pharmaceutical CDMO Services Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Pharmaceutical CDMO Services Revenue Share by Players (2019-2024)

Table 17. Global Top Pharmaceutical CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Services as of 2023)

Table 18. Global Pharmaceutical CDMO Services Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Pharmaceutical CDMO Services Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Pharmaceutical CDMO Services, Headquarters and Area Served

Table 21. Global Key Players of Pharmaceutical CDMO Services, Product and Application

Table 22. Global Key Players of Pharmaceutical CDMO Services, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharmaceutical CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2019-2024)

Table 26. Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2025-2030)

Table 28. Global Pharmaceutical CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Pharmaceutical CDMO Services Revenue Share by Application (2019-2024)

Table 30. Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Pharmaceutical CDMO Services Revenue Share by Application (2025-2030)

Table 32. North America Pharmaceutical CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Pharmaceutical CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Pharmaceutical CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Pharmaceutical CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Pharmaceutical CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Pharmaceutical CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Pharmaceutical CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Pharmaceutical CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Pharmaceutical CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Pharmaceutical CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Pharmaceutical CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Pharmaceutical CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Pharmaceutical CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Pharmaceutical CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Pharmaceutical CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Pharmaceutical CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Pharmaceutical CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Pharmaceutical CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Pharmaceutical CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Pharmaceutical CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Pharmaceutical CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Pharmaceutical CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Pharmaceutical CDMO Services Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Pharmaceutical CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Pharmaceutical CDMO Services Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 64. Recipharm AB Company Details

Table 65. Recipharm AB Business Overview

Table 66. Recipharm AB Pharmaceutical CDMO Services Product

Table 67. Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 68. Recipharm AB Recent Developments

Table 69. AMRI Global Company Details

Table 70. AMRI Global Business Overview

Table 71. AMRI Global Pharmaceutical CDMO Services Product

Table 72. AMRI Global Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 73. AMRI Global Recent Developments

Table 74. Patheon N.V. Company Details

Table 75. Patheon N.V. Business Overview

Table 76. Patheon N.V. Pharmaceutical CDMO Services Product

Table 77. Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 78. Patheon N.V. Recent Developments

Table 79. Aenova Group Company Details

Table 80. Aenova Group Business Overview

Table 81. Aenova Group Pharmaceutical CDMO Services Product

Table 82. Aenova Group Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 83. Aenova Group Recent Developments

Table 84. Catalent, Inc. Company Details

Table 85. Catalent, Inc. Business Overview

Table 86. Catalent, Inc. Pharmaceutical CDMO Services Product

Table 87. Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 88. Catalent, Inc. Recent Developments

Table 89. Amatsigroup Company Details

Table 90. Amatsigroup Business Overview

Table 91. Amatsigroup Pharmaceutical CDMO Services Product

Table 92. Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 93. Amatsigroup Recent Developments

Table 94. WuXi AppTec Group Company Details

Table 95. WuXi AppTec Group Business Overview

Table 96. WuXi AppTec Group Pharmaceutical CDMO Services Product

Table 97. WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 98. WuXi AppTec Group Recent Developments

Table 99. Strides Pharma Science Limited Company Details

Table 100. Strides Pharma Science Limited Business Overview

Table 101. Strides Pharma Science Limited Pharmaceutical CDMO Services Product

Table 102. Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 103. Strides Pharma Science Limited Recent Developments

Table 104. Piramal Pharma Solutions Company Details

Table 105. Piramal Pharma Solutions Business Overview

Table 106. Piramal Pharma Solutions Pharmaceutical CDMO Services Product

Table 107. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 108. Piramal Pharma Solutions Recent Developments

Table 109. Siegfried Ltd Company Details

Table 110. Siegfried Ltd Business Overview

Table 111. Siegfried Ltd Pharmaceutical CDMO Services Product

Table 112. Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 113. Siegfried Ltd Recent Developments

Table 114. Fareva Group Company Details

Table 115. Fareva Group Business Overview

Table 116. Fareva Group Pharmaceutical CDMO Services Product

Table 117. Fareva Group Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 118. Fareva Group Recent Developments

Table 119. FAMAR Health Care Services Company Details

Table 120. FAMAR Health Care Services Business Overview

Table 121. FAMAR Health Care Services Pharmaceutical CDMO Services Product

Table 122. FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 123. FAMAR Health Care Services Recent Developments

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutical CDMO Services Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Pharmaceutical CDMO Services Market Share by Type: 2023 VS 2030

Figure 3. Drug Substance Development and Manufacturing Features

Figure 4. Specialized Services Features

Figure 5. Lab-based Services Features

Figure 6. Global Pharmaceutical CDMO Services Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pharmaceutical CDMO Services Market Share by Application: 2023 VS 2030

Figure 8. Innovative Medicine Case Studies

Figure 9. Patented Drug Case Studies

Figure 10. Patent Expired Drug Case Studies

Figure 11. Pharmaceutical CDMO Services Report Years Considered

Figure 12. Global Pharmaceutical CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Pharmaceutical CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Pharmaceutical CDMO Services Market Share by Region: 2023 VS 2030

Figure 15. Global Pharmaceutical CDMO Services Market Share by Players in 2023

Figure 16. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Services as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2023

Figure 18. North America Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Pharmaceutical CDMO Services Market Share by Type (2019-2030)

Figure 20. North America Pharmaceutical CDMO Services Market Share by Application (2019-2030)

Figure 21. North America Pharmaceutical CDMO Services Market Share by Country (2019-2030)

Figure 22. United States Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Pharmaceutical CDMO Services Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Pharmaceutical CDMO Services Market Share by Type (2019-2030)

Figure 26. Europe Pharmaceutical CDMO Services Market Share by Application (2019-2030)

Figure 27. Europe Pharmaceutical CDMO Services Market Share by Country (2019-2030)

Figure 28. Germany Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Pharmaceutical CDMO Services Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Pharmaceutical CDMO Services Market Share by Type (2019-2030)

Figure 36. China Pharmaceutical CDMO Services Market Share by Application (2019-2030)

Figure 37. Asia Pharmaceutical CDMO Services Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Pharmaceutical CDMO Services Market Share by Type (2019-2030)

Figure 39. Asia Pharmaceutical CDMO Services Market Share by Application (2019-2030)

Figure 40. Asia Pharmaceutical CDMO Services Market Share by Region (2019-2030)

Figure 41. Japan Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Pharmaceutical CDMO Services Market Share by Country (2019-2030)

Figure 51. Brazil Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 58. AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 59. Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 60. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 61. Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 62. Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 63. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 64. Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 65. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 66. Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 67. Fareva Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 68. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

CDMO Market

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions